Sun Pharmaceutical Industries Ltd.

The sales moved up 48.45% to Rs. 59482.20 millions for the March 2023 quarter as compared to Rs. 40068.80 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -10208.20 millions as compared to Net Loss of Rs. -12862.10 millions of corresponding quarter ended March 2022Operating profit surged to 24809.50 millions from the corresponding previous quarter of 13002.50 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202303	202203	% Var	202303	202203	% Var	202303	202203	% Var
Sales	59482.20	40068.80	48.45	208121.40	155859.80	33.53	208121.40	155859.80	33.53
Other Income	1203.00	4404.90	-72.69	3292.90	11968.80	-72.49	3292.90	11968.80	-72.49
PBIDT	24809.50	13002.50	90.81	67518.90	38654.40	74.67	67518.90	38654.40	74.67
Interest	1614.50	911.90	77.05	4721.80	3881.00	21.66	4721.80	3881.00	21.66
PBDT	-6182.90	-4459.00	38.66	33419.20	16568.10	101.71	33419.20	16568.10	101.71
Depreciation	4119.80	3541.40	16.33	16008.70	13499.50	18.59	16008.70	13499.50	18.59
PBT	-10302.70	-8000.40	28.78	17410.50	3068.60	467.38	17410.50	3068.60	467.38
TAX	-94.50	4861.70	-101.94	503.30	4068.50	-87.63	503.30	4068.50	-87.63
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	-10208.20	-12862.10	-20.63	16907.20	-999.90	-1790.89	16907.20	-999.90	-1790.89
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	41.71	32.45	28.53	32.44	24.80	30.81	32.44	24.80	30.81